Immunoglobulin G4 [221-proline], anti-(human programmed cell death protein 1) (human monoclonal SG001 ?4-chain), disulfide with human monoclonal SG001 ?-chain, dimer
Relapsed or Refractory Peripheral T Cell Lymphoma
Sun Yat-Sen University Cancer Centermonoclonal_antibodyPhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 95/ 100
Competitive context
135 Active assets in the Relapsed or Refractory Peripheral T Cell Lymphoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Pralatrexate Peking University People's Hospital | Phase 4 | BBB |
PREDNISONE TABLETS Tarapeutics Science Inc. | Phase 4 | BBB |
Inno-206 BeBetter Med Inc | Phase 4 | BBB |
(+)-VINCRISTINE BeBetter Med Inc | Phase 4 | BBB |
Cyclophosphamide Tarapeutics Science Inc. | Phase 4 | BBB |
View all 50 →
Same molecule, other indications
Immunoglobulin G4 [221-proline], anti-(human programmed cell death protein 1) (human monoclonal SG001 ?4-chain), disulfide with human monoclonal SG001 ?-chain, dimer is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →